Momentum builds for small cap biotechs
Capital dedicated by local investors to risky investments that was once largely tied up in...
Capital dedicated by local investors to risky investments that was once largely tied up in...
The company’s goal is to harness OmniCAR’s innate adaptability and control to develop novel cell...
Anti-cancer biotech company Prescient Therapeutics (PTX) has received two key licences to build a new...
ASX listed biotech company Prescient Therapeutics (ASX: PTX) has this week unveiled two significant licence...
Biotech company Prescient Therapeutics (ASX: PTX) emerged from a trading halt this morning to unveil two significant...
Anti-cancer biotech company Prescient Therapeutics (PTX) has received two key licences to build a new...
It is impossible to overstate the unprecedented disruptions the world is facing with COVID-19. Stock...
AFL player Ben Brown recently shared a story about his cousin Grace’s battle with cancer,...
Cancer is the leading cause of death in Australia, claiming almost 50,000 lives in 2019....
When you think of cancer therapies, you may automatically think of chemo and radiation. While...
This investor centre was built by Reach Markets
©2022 Reach Markets
To stay up to date with Prescient Therapeutics news and events, please register your details.